Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.
Dodt
J E
JE
Byerly
M J
MJ
Cuadros
C
C
Christensen
R C
RC
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D018967:Risperidone / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
D015057:1-Naphthylamine; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline